Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+7.47%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$56.6B
AUM Growth
+$56.6B
(+4.9%)
Cap. Flow
+$402M
Cap. Flow
% of AUM
0.71%
Top 10 Holdings %
Top 10 Hldgs %
29.54%
Holding
970
New
110
Increased
281
Reduced
398
Closed
105
Top Buys
| 1 |
Broadcom
AVGO
|
$662M |
| 2 |
HES
Hess
HES
|
$285M |
| 3 |
3M
MMM
|
$208M |
| 4 |
Bristol-Myers Squibb
BMY
|
$187M |
| 5 |
Dover
DOV
|
$150M |
Top Sells
| 1 |
CSX Corp
CSX
|
$201M |
| 2 |
Merck
MRK
|
$191M |
| 3 |
Deere & Co
DE
|
$122M |
| 4 |
RB Global
RBA
|
$108M |
| 5 |
ConocoPhillips
COP
|
$106M |
Sector Composition
| 1 | Technology | 28.49% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 10.57% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Amalgamated Financial
AMAL
$856M
| $22.5M | 0.04% |
716,262
-816,543
| -53% | -$25.6M |
|
427
Church & Dwight Co
CHD
$22.7B
| $22.1M | 0.04% |
210,774
+72,700
| +53% | +$7.61M |
|
428
TScan Therapeutics
TCRX
$99.3M
| $21.9M | 0.04% |
4,400,000
| – | – |
|
429
MeiraGTx Holdings
MGTX
$587M
| $21.8M | 0.04% |
5,229,099
| – | – |
|
|
SRCL
430
DELISTED
Stericycle Inc
SRCL
| $21.5M | 0.04% |
353,003
-249,962
| -41% | -$15.2M |
|
431
Raymond James Financial
RJF
$33.6B
| $21.4M | 0.04% |
174,750
-4,200
| -2% | -$514K |
|
|
TLN
432
Talen Energy Corporation Common Stock
TLN
$17.1B
| $21.4M | 0.04% |
+120,000
| New | +$21.4M |
|
433
Brixmor Property Group
BRX
$8.48B
| $21.3M | 0.04% |
765,000
-635,000
| -45% | -$17.7M |
|
434
Sunstone Hotel Investors
SHO
$1.77B
| $21.2M | 0.04% |
2,050,000
+100,000
| +5% | +$1.03M |
|
435
Tapestry
TPR
$21.4B
| $21.1M | 0.04% |
+449,831
| New | +$21.1M |
|
436
Iron Mountain
IRM
$26.4B
| $21M | 0.04% |
176,452
-104,700
| -37% | -$12.4M |
|
437
Dell
DELL
$81.8B
| $20.9M | 0.04% |
+176,200
| New | +$20.9M |
|
438
GoDaddy
GDDY
$20B
| $20.8M | 0.04% |
132,900
-2,300
| -2% | -$361K |
|
439
CRH
CRH
$74.7B
| $20.6M | 0.04% |
+222,000
| New | +$20.6M |
|
440
Tyler Technologies
TYL
$23.9B
| $20.5M | 0.04% |
35,200
-5,500
| -14% | -$3.21M |
|
441
Abeona Therapeutics
ABEO
$351M
| $20.5M | 0.04% |
3,249,994
| – | – |
|
442
Compass Therapeutics
CMPX
$474M
| $20.5M | 0.04% |
11,130,000
| – | – |
|
443
Enliven Therapeutics
ELVN
$1.24B
| $20.4M | 0.04% |
800,000
-40,000
| -5% | -$1.02M |
|
|
SOC.WS
444
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
| $20.4M | 0.04% |
1,686,217
-136,217
| -7% | -$1.65M |
|
|
BCAX
445
Bicara Therapeutics Inc. Common Stock
BCAX
$649M
| $20.4M | 0.04% |
+800,000
| New | +$20.4M |
|
446
Cboe Global Markets
CBOE
$24.3B
| $20.2M | 0.04% |
98,600
-2,300
| -2% | -$471K |
|
447
Viavi Solutions
VIAV
$2.57B
| $20.2M | 0.04% |
2,236,202
+10,000
| +0.4% | +$90.2K |
|
448
Steel Dynamics
STLD
$19B
| $20.1M | 0.04% |
159,300
+17,600
| +12% | +$2.22M |
|
449
Perella Weinberg Partners
PWP
$1.36B
| $20M | 0.04% |
1,037,615
-286,664
| -22% | -$5.54M |
|
450
Ionis Pharmaceuticals
IONS
$9.16B
| $20M | 0.04% |
500,000
-300,000
| -38% | -$12M |
|